AllSides Balanced Search reveals information and ideas from all sides of the political spectrum so you can get the full picture.
Jun 10 2021
News
U.S. to donate 500 million Pfizer doses to poor nations
The United States will spend $3.5 billion to buy and donate 500 million doses of the Pfizer (PFE.N) coronavirus vaccine to some of the world’s poorest countries, it said on Thursday, urging other G7 nations to follow suit.
The vaccine donation - the largest ever by a single country - was announced before U.S. President Joe Biden meets leaders of the Group of Seven advanced economies in
ReutersMay 10 2021
News
FDA Clears Pfizer Coronavirus Vaccine For Children As Young As 12
The Food and Drug Administration (FDA) expanded its emergency use authorization for the Pfizer coronavirus vaccine to children as young as 12 Monday, the first COVID-19 vaccine to receive the green light.
The FDA had previously approved both the Pfizer and Moderna vaccines on children ages 16 and up, but Pfizer is the first vaccine now available to all teenagers. A CDC panel will meet
The Daily CallerMay 12 2021
News
CDC recommends Pfizer's COVID vaccine for kids as young as 12
The CDC has formally adopted a recommendation from a panel of its independent advisers to use Pfizer's COVID-19 vaccine in adolescents age 12 to 15, clearing the final remaining federal hurdle to making the shots available to all Americans as young as 12.
CBS News (Online)May 10 2021
News
The F.D.A. authorizes the Pfizer-BioNTech vaccine for children 12 to 15.
The Food and Drug Administration on Monday authorized use of the Pfizer-BioNTech Covid-19 vaccine for 12- to 15-year-olds in the United States, a crucial step in the nation’s steady recovery from the pandemic and a boon to tens of millions of American families eager for a return to normalcy.
The authorization caps weeks of anticipation among parents, who have been grappling with how to
New York Times (News)May 04 2021
News
Pfizer Reaps Hundreds of Millions in Profits From Covid Vaccine
Last year, racing to develop a vaccine in record time, Pfizer made a big decision: Unlike several rival manufacturers, which vowed to forgo profits on their shots during the Covid-19 pandemic, Pfizer planned to profit on its vaccine.
On Tuesday, the company announced just how much money the shot is generating.
The vaccine brought in $3.5 billion in revenue in the first three
New York Times (News)Aug 31 2022
News
FDA authorizes Pfizer and Moderna Covid boosters targeted against Omicron strains
The Food and Drug Administration on Wednesday authorized new Covid booster shots from Moderna and Pfizer that more closely match the strains of the coronavirus that are currently circulating in the U.S.
Pfizer’s booster, made with partner BioNTech, is being authorized for people as young as 12 years old. The Moderna booster is being authorized for people ages 18 and up.
Use of
STATMar 08 2021
News
Pfizer’s coronavirus vaccine neutralizes Brazil variant in lab study
The Pfizer coronavirus vaccine is able to neutralize a rapidly spreading virus variant from Brazil, according to a new laboratory study.
Researchers developed an engineered version of the COVID-19 mutation and found that blood samples taken from people who received the vaccine were able to neutralize the variant, according to the study published in the New England Journal of Medicine on
New York Post (News)Jan 25 2022
News
Pfizer, BioNTech begin omicron-specific COVID-19 vaccine study
COVID-19 vaccine-makers Pfizer and BioNTech announced Tuesday that they would test an omicron-specific vaccine candidate in healthy adults ages 18 to 55.
The companies said there would be three trials examining different regimens of the current Pfizer-BioNTech vaccine for an omicron-based vaccine.
The study will also draw upon some participants from the companies’ Phase 3 COVID-
Fox BusinessJan 27 2022
News
How to think about boosters in light of this week's Pfizer and Moderna news
Pfizer and BioNTech announced Tuesday that they're beginning a clinical trial for an Omicron-specific Covid-19 vaccine, and Moderna revealed Wednesday that it has entered Phase 2 of its own trial of a vaccine that targets the variant, which is by far the dominant one in the United States right now.
About 50% of eligible Americans have received a booster shot, according to the US Centers
CNN (Online News)Dec 23 2020
News
U.S. buys another 100 million doses of Pfizer vaccine
The Trump administration has reached an agreement with Pfizer and BioNTech to purchase 100 million additional doses of their coronavirus vaccine, which will be fully delivered no later July 31, 2021, the Department of Health and Human Services announced Wednesday.
Why it matters: The deal will allow millions more Americans to be vaccinated at zero cost by next fall. Under the terms of
Axios